These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11575008)

  • 21. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
    Carey W; Warrington S; Boyce M; Luria X
    Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research.
    Gelfand EW; Appajosyula S; Meeves S
    Curr Med Res Opin; 2004 Jan; 20(1):73-81. PubMed ID: 14741075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential cardiac toxicity of H1-antihistamines.
    Yap YG; Camm AJ
    Clin Allergy Immunol; 2002; 17():389-419. PubMed ID: 12113224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiotoxicity of new antihistamines and cisapride.
    Paakkari I
    Toxicol Lett; 2002 Feb; 127(1-3):279-84. PubMed ID: 12052668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular toxicity of antihistamines.
    Smith SJ
    Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 2):348-54. PubMed ID: 7916150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating allergic rhinitis with second-generation antihistamines.
    Nightingale CH
    Pharmacotherapy; 1996; 16(5):905-14. PubMed ID: 8888086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of potassium channels by nonsedating antihistamines.
    Berul CI; Morad M
    Circulation; 1995 Apr; 91(8):2220-5. PubMed ID: 7697852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of nonsedative antihistamines. II. Assessment of its antihistaminic potency.
    Aparicio S; Granel C; Randazzo L; Valencia M; Olivé Pérez A
    Allergol Immunopathol (Madr); 1992; 20(5):207-10. PubMed ID: 1363340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels.
    Valenzuela C; Delpón E; Franqueza L; Gay P; Vicente J; Tamargo J
    Eur J Pharmacol; 1997 May; 326(2-3):257-63. PubMed ID: 9196279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
    Suessbrich H; Waldegger S; Lang F; Busch AE
    FEBS Lett; 1996 Apr; 385(1-2):77-80. PubMed ID: 8641472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine.
    Salata JJ; Jurkiewicz NK; Wallace AA; Stupienski RF; Guinosso PJ; Lynch JJ
    Circ Res; 1995 Jan; 76(1):110-9. PubMed ID: 8001268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
    Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
    Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of antihistamines in children.
    Ten Eick AP; Blumer JL; Reed MD
    Drug Saf; 2001; 24(2):119-47. PubMed ID: 11235817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.
    Grant JA; Danielson L; Rihoux JP; DeVos C
    Allergy; 1999 Jul; 54(7):700-7. PubMed ID: 10442525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terfenadine, astemizole, and ebastine produce QTc interval prolongation in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Egan RW; Kreutner W
    Ann Allergy Asthma Immunol; 1996 May; 76(5):476. PubMed ID: 8630724
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of histamine H1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles.
    Ki I; Inui A; Ito T
    Arch Int Pharmacodyn Ther; 1996; 331(1):59-73. PubMed ID: 8896711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects.
    Kaliner MA
    Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.
    Chaikin P; Gillen MS; Malik M; Pentikis H; Rhodes GR; Roberts DJ
    Br J Clin Pharmacol; 2005 Mar; 59(3):346-54. PubMed ID: 15752381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
    Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.